How good a marker is insulin level for insulin resistance?

American Journal of Epidemiology

Volumn 137, Issue 9, 1993, Pages 959-965

  Laakso, Markku ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Diabetes mellitus, non insulin dependent; Glucose; Glucose tolerance test; Insulin; Insulin resistance

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DIET RESTRICTION; FINLAND; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGE; SUPPORT, NON-U.S. GOV'T;

EID: 0027180608     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a116768     Document Type: Article

References (28)

1. Pyorala K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 1979;2:131-41.
2. Ducimetiere P, Eschwege E, Papoz L, et al. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetolo-gia 1980;19:205-10.
3. Welbom TA. Weame K. Coronary heart disease incidence and cardiovascular mortality in Bussel-ton with reference to glucose and insulin concentration. Diabetes Care 1979;2:154-60.
4. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
5. Orchard TJ, Becker DJ, Bates M, et al. Plasma insulin and lipoprotein concentrations: an atherogenic association? Am J Epidemiol 1983:118: 326-37.
6. Laakso M, Pyorala K, Voutilainen E, et al. Plasma insulin, serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetic and nondiabetic subjects. Am J Epidemiol 1987; 125: 611-21.
7. Laakso M, Barrett-Connor E. Asymptomatic hyperglycemia is associated with lipid and lipoprotein changes favouring atherosclerosis. Arteriosclerosis 1989;9:665-72.
8. Modan M, Halkin H, Almog S, et al. Hyperinsulin-emia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 1985;75:809-17.
9. Manicardi V, Camellini L, Bellodi G, et al. Evidence for an association of high blood pressure and hyperinsulinemia in obese man. J Clin Endocrinol Metab 1986;62:1302-4.
10. Olefsky JM, Farquhar JW, Reaven GM. Relationship between fasting plasma insulin level and resistance to insulin-mediated glucose uptake in normal and diabetic subjects. Diabetes 1973, 22: 507-13.
11. Reaven GM, Olefsky JM. Relationship between heterogeneity of insulin responses and insulin resistance in normal subjects and patients with chemical diabetes. Diabetologia 1977;13:201-6.
12. Nagulesparan M, Savage PJ, Unger RH, et al. A simplified method using somatostatin to assess in vivo insulin resistance over a range of obesity. Diabetes 1979;28:980-3.
13. Hollenbeck CB, Chen N, Chen Y-DI, et al. Relationship between the plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects. Diabetes 1984;33:460-4.
14. Lillioja S. Mott DM. Zawadski JK, et al. In vivo insulin action is familial characteristic in nondiabetic Pima Indians. Diabetes 1987;36:1329-35.
15. Hollenbeck C, Reaven GM. Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance. J Clin Endocrinol Metab 1987:64:1169-73.
16. Lampman RM, Schteingart DE, Santinga JT, et al. The influence of physical training on glucose tolerance, insulin sensitivity, and lipid and lipoprotein concentrations in middle-aged hypertriglyceri-daemic, carbohydrate intolerant men. Diabetologia 1987;30:380-5.
17. Bogardus C, Lillioja S, Nyomba BL, et al. Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions. Diabetes 1989;38:1423-32.
18. Haffner SM, Stem MP, Dunn J, et al. Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans. Metabolism 1990;39:842-7.
19. Ho LT, Chang ZY, Wang JT, et al. Insulin insen-sitivity in offspring of parents with Type 2 diabetes mellitus. Diabetic Med 1989;7:31-4.
20. Golay A, Chen N, Chen Y-DI, et al. Effect of central obesity on regulation of carbohydrate metabolism in obese patients with varying degrees of glucose tolerance. J Clin Endocrinol Metab 1990; 71:1299-1304.
21. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979:237: E214-23.
22. Laakso M, Sarlund H, Mykkanen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 1990;10:223-32.
23. Laakso M, Ronnemaa T., Pyorala K, et al. Atherosclerotic vascular disease and its risk factors in noninsulin-dependent diabetic and nondiabetic subjects in Finland. Diabetes Care 1988; 1:449-63.
24. Mykkanen L, Laakso M, Uusitupa M, et al. Prevalence of diabetes and impaired glucose tolerance in elderly subjects and their association with obesity and family history of diabetes. Diabetes Care 1990; 13:1099-1105.
25. World Health Organization. Diabetes mellitus. Report of a WHO Study Group. Geneva, Switzerland: World Health Organization, 1985:11-20. (Technical report series 727).
26. DeBodo RC, Steele R, Altszuler N, et al. On the hormonal regulation of carbohydrate metabolism: studies with Cl 4-glucose. Recent Prog Horm Res 1963:19:445-82.
27. Norusis MJ. SPSS/PC+ for the IBM PC/XT/AT. Chicago, IL: SPSS Inc, 1986.
28. DeFronzo RA. The triumvirate: beta-cell, muscle, liver a collusion responsible for NIDDM. Diabetes 1988;37:667-87.